RHOA and ovarian serous carcinoma: These two cases were also rearranged for TSHZ3. ARHGAP6 functions as a GAP for RhoA GTPase, which has been implicated in cell motility, and angiogenesis and has been reported to be up-regulated in multiple cancers, including serous ovarian carcinomas 28.